Sucampo Pharmaceuticals Competitors and Similar CompaniesClear all
Sucampo Pharmaceuticals's competitors and similar companies include Amicus Therapeutics, Biofrontera, BTG and Skyepharma.
 Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | |||
Founding Date | Founding Date 1996 | Founding Date 2002 | Founding Date 2012 | Founding Date 1948 | Founding Date 1996 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Leverkusen, DE HQ | Locations Saint-Quentin-Fallavier, FR HQ | |
Employees | Employees 37 | Employees 58415% increase | Employees 91 | Employees 650 | Employees 2453% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.4 b | Valuation ($) 1.1 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) £95.9m (FY, 2015) |
Cost of goods | Cost of goods $76m (FY, 2016) | Cost of goods $72.9m (FY, 2025) | Cost of goods €2.2m (FY, 2025) | Cost of goods £221m (FY, 2019) | Cost of goods £43.1m (FY, 2015) |
Gross profit | Gross profit $154.1m (FY, 2016) | Gross profit $561.3m (FY, 2025) | Gross profit €11.2m (FY, 2025) | Gross profit £510.3m (FY, 2019) | Gross profit £52.8m (FY, 2015) |
Net income | Net income $18.5m (FY, 2016) | Net income ($27.1m) (FY, 2025) | Net income (€6.9m) (FY, 2025) | Net income £88.3m (FY, 2019) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View companyBiofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company
Skyepharma
HQ
Saint-Quentin-Fallavier, FR
Skyepharma is a drug delivery company developing oral and inhalation products.
View company